Loading…
Loading…
MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #ClaritevCares--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable and transparent for all, today announced that Claritev Cares, its nonprofit foundation focused on expanding access to healthcare, has awarded its 2026 Rural Health Grants to Fairfield Memorial Hospital in Fairfield, Illinois, and Kodiak Community Health Center in Kodiak, Alaska. The grants will help address two very real barriers to ru.
MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data, and insights company, today announced that members of its management team will meet with investors at the following events in September 2026: Wells Fargo 21st Annual Healthcare Conference – Wednesday, September 9, 2026, at the Encore Boston Harbor – one-on-one meetings J.P. Morgan 4th Annual Healthcare Credit Conference - Thursday, September 10, 2026, at The Joseph Nashv.
MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #ClaimsManagement--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company, today announced that Marpai, Inc. (OTCQX: MRAI) has expanded its relationship with Claritev to bring comprehensive pre- and post-payment integrity capabilities to the health plans and claims it administers. Marpai currently uses Claritev's PHCS® Network to provide access to healthcare providers and negotiated rates outside its clients' primary networks. The expanded agreement ex.
Claritev Corp (NYSE:CTEV) on Friday reported better-than-expected second-quarter financial results and raised its FY26 sales guidance above estimates.
Claritev NYSE: CTEV reported second-quarter revenue growth, record bookings and higher cash flow, prompting the healthcare technology company to raise its full-year revenue, adjusted EBITDA and free-cash-flow outlook.
Claritev Corporation (CTEV) Q2 2026 Earnings Call Transcript
Claritev Corporation (CTEV) came out with a quarterly loss of $3.49 per share versus the Zacks Consensus Estimate of a loss of $4.1. This compares to earnings of $0.32 per share a year ago.
MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the second quarter ended June 30, 2026. “Claritev once again demonstrated the strength of our vision and strategy in the second quarter of 2026, delivering financial results above expectations with solid execution across the company. We are one year i.